ArticleMicrobiologyOpen2026
Quercetin: A Light in the Fight Against MRSA.
Article in MicrobiologyOpen, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- cRGD-Targeted Nanoparticles Co-Loaded with Ag, Quercetin and PD-L1 siRNA with Combined Antibacterial and Immunotherapeutic Functions AgainstInternational journal of nanomedicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
13 authors.
Funding
Abstract
Antimicrobial photodynamic therapy (aPDT) for treating methicillin-resistant Staphylococcus aureus (MRSA) infections has gained increasing attention in recent years. This study aimed to evaluate the potential of quercetin as a photosensitizer for aPDT. In vitro assays were conducted to assess the cytotoxicity and the antibacterial activity of quercetin photoactivated with blue LED light. In in vivo assays, and intradermal infection model was conducted in mice to evaluate the quercetin antimicrobial activity and cytokine production. The in vitro experiments showed low compound toxicity and antimicrobial activity accompanied by the generation of singlet oxygen. BALB/c mice infected with MRSA and treated with quercetin exhibited a reduced bacterial load in the draining lymph nodes and decreased recruitment of polymorphonuclear cells at the infection site. In response to infection, a strong interaction between the cytokines IL-12 and TNF-α was observed in the groups treated with quercetin. These observations support quercetin's anti-inflammatory and antimicrobial potential in infections with resistant strains of MRSA.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.